JOURNAL OF EMERGING AND RARE DISEASES (ISSN:2517-7397)

Aims and Scope

The Journal of Emerging and Rare Diseases publishes high-quality contributions in (but not limited to) the following areas:

• Clinical research on rare diseases and orphan disorders

• Epidemiology and surveillance of emerging diseases

• Genetic, molecular, and cellular mechanisms of rare conditions

• Innovative diagnostic tools and biomarkers

• Novel therapeutic strategies, including gene and cell therapy

• Global health perspectives and neglected diseases

• Infectious diseases with emerging or re-emerging trends

• Case reports and clinical series documenting rare or unusual presentations

• Health policy, regulatory aspects, and patient advocacy for rare diseases

• Public health strategies for preparedness and disease management

Why Publish with JERD?

• Global Readership – Open access ensures research is visible and accessible to clinicians, scientists, and policymakers worldwide.

• Rigorous Peer Review – Submissions undergo a double-blind peer review process, ensuring quality, originality, and fairness.

• Rapid Dissemination – Accepted articles are published online quickly, maximizing impact and visibility.

• Expert Editorial Board – Guided by leading experts in rare diseases, emerging infections, molecular medicine, and public health.

• Diverse Article Types – Welcomes original research, reviews, case studies, short communications, clinical reports, and perspectives.

• Author Rights – Authors retain copyright under Creative Commons licensing, allowing broad reuse and citation.

• Cross-Disciplinary Impact – Encourages collaboration between medicine, genetics, biotechnology, and policy fields.

Editorial & Ethical Standards

The Journal of Emerging and Rare Diseases follows internationally recognized guidelines, including COPE and ICMJE, ensuring transparency, accountability, and integrity in publishing. Editorial decisions are based solely on scientific merit and adherence to ethical standards.